-
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
The risk of hip fracture goes up for about 6 weeks immediately after older people start taking antihypertensives.
-
-
The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) trial compared strict rate control vs lenient rate control in patients with permanent atrial fibrillation.
-
Mediterranean diet can reduce risk for stroke
-
The frequency of isolation of carbapenem-resistant Enterobacteriaceae is increasing in the U.S., with the highest prevalence in the northeastern region.
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
Atrial fibrillation (AF) is a major source of morbidity in patients and cost to the health care community. In the presence of risk factors for thromboembolism, AF is associated with an increased risk of stroke, and this risk is reduced with warfarin. However, warfarin has limitations, including the risk of bleeding and the need for regular blood tests. The
-
Noninvasive ventilation has previously been shown to improve outcomes in studies of patients with acute respiratory failure secondary to an acute exacerbation of COPD. This study confirms the effectiveness of noninvasive ventilation in a large population-based registry and also demonstrates the wide variability of implementation and significant under-utilization of this therapy.
-
At this time, ventricular fibrillation (VF) early after acute myocardial infarction (MI) is not an indication alone for an implantable cardioverter-defibrillator (ICD) therapy. However, there is concern that despite the efficacy of mechanical and pharmacological therapy for acute MI, the risk of subsequent sudden cardiac death (SCD) in patients with VF complicating acute MI may be higher and the guidelines should be revisited.